Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Wilschanski

Showing results (81-90 of 159) with videos related to

Pageof 16
Sort By:
The New England Journal of Medicine|October 10, 2003
Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutationsMichael Wilschanski, Yaacov Yahav, Yasmin Yaacov, et al.
Journal of Cancer|January 7, 2015
Colon Cancer Associated Transcript-1 (CCAT1) Expression in Adenocarcinoma of the StomachIdo Mizrahi, Haggi Mazeh, Ronit Grinbaum, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 24, 2019
Nasal potential difference in suspected cystic fibrosis patients with 5T polymorphismBente L Aalbers, Yasmin Yaakov, Nico Derichs, et al.
The Journal of Clinical Investigation|February 10, 2007
Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicinLiat Linde, Stephanie Boelz, Malka Nissim-Rafinia, et al.
Clinical Nutrition (Edinburgh, Scotland)|April 13, 2016
ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosisDominique Turck, Christian P Braegger, Carla Colombo, et al.
Plos One|October 2, 2014
A novel familial mutation in the PCSK1 gene that alters the oxyanion hole residue of proprotein convertase 1/3 and impairs its enzymatic activityMichael Wilschanski, Montaser Abbasi, Elias Blanco, et al.
Frontiers in Pediatrics|March 20, 2023
Infantile-onset inflammatory bowel disease has variable long-term outcomesAlex Krauthammer, Ilana Weintraub, Ron Shaoul, et al.
The European Respiratory Journal|October 27, 2012
Influence of perfusate temperature on nasal potential differenceInez Bronsveld, François Vermeulen, Dorotha Sands, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 8, 2026
Intestinal organoids as a platform for functional evaluation of ASO-mediated splicing modulation in cystic fibrosisNoemie Stanleigh, Michal Irony-Tur Sinai, Yifat Oren, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 12, 2013
Nasal potential difference measurements in diagnosis of cystic fibrosis: an international surveyLutz Naehrlich, Manfred Ballmann, Jane Davies, et al.
Pageof 16

Showing results (81-90 of 159) with videos related to

Sort By:
Pageof 16
The New England Journal of Medicine|October 10, 2003
Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutationsMichael Wilschanski, Yaacov Yahav, Yasmin Yaacov, et al.
Journal of Cancer|January 7, 2015
Colon Cancer Associated Transcript-1 (CCAT1) Expression in Adenocarcinoma of the StomachIdo Mizrahi, Haggi Mazeh, Ronit Grinbaum, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 24, 2019
Nasal potential difference in suspected cystic fibrosis patients with 5T polymorphismBente L Aalbers, Yasmin Yaakov, Nico Derichs, et al.
The Journal of Clinical Investigation|February 10, 2007
Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicinLiat Linde, Stephanie Boelz, Malka Nissim-Rafinia, et al.
Clinical Nutrition (Edinburgh, Scotland)|April 13, 2016
ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosisDominique Turck, Christian P Braegger, Carla Colombo, et al.
Plos One|October 2, 2014
A novel familial mutation in the PCSK1 gene that alters the oxyanion hole residue of proprotein convertase 1/3 and impairs its enzymatic activityMichael Wilschanski, Montaser Abbasi, Elias Blanco, et al.
Frontiers in Pediatrics|March 20, 2023
Infantile-onset inflammatory bowel disease has variable long-term outcomesAlex Krauthammer, Ilana Weintraub, Ron Shaoul, et al.
The European Respiratory Journal|October 27, 2012
Influence of perfusate temperature on nasal potential differenceInez Bronsveld, François Vermeulen, Dorotha Sands, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 8, 2026
Intestinal organoids as a platform for functional evaluation of ASO-mediated splicing modulation in cystic fibrosisNoemie Stanleigh, Michal Irony-Tur Sinai, Yifat Oren, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 12, 2013
Nasal potential difference measurements in diagnosis of cystic fibrosis: an international surveyLutz Naehrlich, Manfred Ballmann, Jane Davies, et al.
Pageof 16